Utility of the Neutrophil/Lymphocyte Ratio for Predicting Malignancy Risk and Prognosis in Patients With Dermatomyositis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical and Experimental Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Utility of the Neutrophil/Lymphocyte Ratio for Predicting Malignancy Risk and Prognosis in Patients With Dermatomyositis
Clin Exp Dermatol 2019 Nov 06;[EPub Ahead of Print], AA Galadari, LD Sun, AP FernandezFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.